Literature DB >> 17614260

Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis.

Stéphane Potvin1, Christian C Joyal, Julie Pelletier, Emmanuel Stip.   

Abstract

Although a substance use disorder (SUD) is traditionally associated with psycho-bio-social impairments, recent investigations among persons with schizophrenia (Sz) generated divergent results. Certain persons with Sz+SUD might in fact present better social and cognitive functioning than persons with Sz without SUD. This meta-analysis was conducted to verify this counterintuitive possibility and to determine whether factors such as substance type, severity or nature of psychotic symptoms and age of the patients help discriminate these subgroups. Twenty-three studies met the inclusion criteria and data from 1807 persons with schizophrenia, with or without comorbid SUD, were available for analyses. As a group, persons with Sz+SUD did not obtain significantly higher scores at a Global Cognitive Index than persons with Sz without SUD, although they were better at the Trail Making Task and the speed processing domain. Secondary analyses showed the importance of considering intermediate factors, particularly the preferred substance used and the mean age. While consumption of alcohol was associated with a global cognitive scores similar to that of persons with Sz without an SUD and lower working memory capacities, preferential use of cannabis was instead associated with higher scores for problem solving and reasoning and visual memory. Age was inversely related to the size of the effects. It is concluded that previous mixed results obtained with cognitive evaluations of persons with Sz+SUD might reflect the heterogeneity of participants and that subgroups of patients might be defined on the basis of intermediate factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17614260     DOI: 10.1016/j.schres.2007.04.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  29 in total

1.  Adverse Effects of Cannabis Use on Neurocognitive Functioning: A Systematic Review of Meta- Analytic Studies.

Authors:  Jacqueline C Duperrouzel; Karen Granja; Ileana Pacheco-Colón; Raul Gonzalez
Journal:  J Dual Diagn       Date:  2019-06-22

2.  Neurocognitive functioning of individuals with schizophrenia: using and not using drugs.

Authors:  Amber L Bahorik; Christina E Newhill; Shaun M Eack
Journal:  Schizophr Bull       Date:  2013-07-24       Impact factor: 9.306

Review 3.  Violent behaviour among people with schizophrenia: a framework for investigations of causes, and effective treatment, and prevention.

Authors:  Sheilagh Hodgins
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-08-12       Impact factor: 6.237

4.  Auditory mismatch negativity deficits in long-term heavy cannabis users.

Authors:  Patrik Roser; Beate Della; Christine Norra; Idun Uhl; Martin Brüne; Georg Juckel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02-02       Impact factor: 5.270

5.  [Substance use associated disorders: frequency in patients with schizophrenic and affective psychoses].

Authors:  L Hermle; R Szlak-Rubin; K L Täschner; P Peukert; A Batra
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

6.  Longitudinal Course of Clients With Co-occurring Schizophrenia-Spectrum and Substance Use Disorders in Urban Mental Health Centers: A 7-Year Prospective Study.

Authors:  Robert E Drake; Alison E Luciano; Kim T Mueser; Nancy H Covell; Susan M Essock; Haiyi Xie; Gregory J McHugo
Journal:  Schizophr Bull       Date:  2015-08-19       Impact factor: 9.306

Review 7.  Does Gender Influence Outcome in Schizophrenia?

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2019-03

Review 8.  Endocannabinoid system: potential novel targets for treatment of schizophrenia.

Authors:  Atsushi Saito; Michael D L Ballinger; Mikhail V Pletnikov; Dean F Wong; Atsushi Kamiya
Journal:  Neurobiol Dis       Date:  2012-12-07       Impact factor: 5.996

9.  Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.

Authors:  Ana M Sánchez-Torres; Virginia Basterra; Araceli Rosa; Lourdes Fañanás; Amalia Zarzuela; Berta Ibáñez; Víctor Peralta; Manuel J Cuesta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-04-12       Impact factor: 5.270

10.  Cannabis use and cognition in schizophrenia.

Authors:  Else-Marie Løberg; Kenneth Hugdahl
Journal:  Front Hum Neurosci       Date:  2009-11-24       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.